Association of cognitive function and hypoperfusion in Moyamoya disease patients without strokeXuxuan Shen, Cong Han, Hou-Di Zhang et al.|Journal of Cerebral Blood Flow & Metabolism|2022Cited by 25
Vessel wall enhancement as a predictor of arterial stenosis progression and poor outcomes in moyamoya diseaseMingming Lu, Jianming Cai, Fangbin Hao et al.|European Radiology|2022Cited by 21
Long-term outcomes of moyamoya disease versus atherosclerosis-associated moyamoya vasculopathy using high-resolution MR vessel wall imagingMingming Lu, Jianming Cai, Hongtao Zhang et al.|Journal of Neurology Neurosurgery & Psychiatry|2023Cited by 20
The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated moyamoya vasculopathy from moyamoya diseaseShitong Liu, Jianming Cai, Mingming Lu et al.|European Radiology|2023Cited by 20
<i>HAPLN3</i> p.<scp>T34A</scp> contributes to incomplete penetrance of moyamoya disease in Chinese carrying <i>RNF213</i> p.<scp>R4810K</scp>Jun Xu, Lian Duan, Zhengxing Zou et al.|European Journal of Neurology|2024Cited by 6